82 FR 51293 - Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2017

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 82, Issue 212 (November 3, 2017)

Page Range		51293-51298
FR Document		2017-24009
This final order establishes the final adjusted 2017 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Federal Register, Volume 82 Issue 212 (Friday, November 3, 2017)
[Federal Register Volume 82, Number 212 (Friday, November 3, 2017)]
[Notices]
[Pages 51293-51298]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-24009]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-470F]


Final Adjusted Aggregate Production Quotas for Schedule I and II 
Controlled Substances and Assessment of Annual Needs for the List I 
Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2017

AGENCY: Drug Enforcement Administration (DEA), Department of Justice 
(DOJ).

ACTION: Final order.

-----------------------------------------------------------------------

SUMMARY: This final order establishes the final adjusted 2017 aggregate 
production quotas for controlled substances in schedules I and II of 
the Controlled Substances Act and the assessment of annual needs for 
the list I chemicals ephedrine, pseudoephedrine, and 
phenylpropanolamine.

DATES: This order is applicable November 3, 2017.

FOR FURTHER INFORMATION CONTACT: Michael J. Lewis, Diversion Control 
Division, Drug Enforcement Administration, 8701 Morrissette Drive, 
Springfield, VA 22152, Telephone: (202) 598-6812.

SUPPLEMENTARY INFORMATION: 

Legal Authority

    Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) 
requires the Attorney General to establish aggregate production quotas 
for each basic class of controlled substances listed in schedules I and 
II and for the list I chemicals ephedrine, pseudoephedrine, and 
phenylpropanolamine. The Attorney General has delegated this function 
to the Administrator of the Drug Enforcement Administration (DEA) 
pursuant to 28 CFR 0.100.

Background

    The DEA published the 2017 established aggregate production quotas 
for controlled substances in schedules I and II and for the assessment 
of annual needs for the list I chemicals ephedrine, pseudoephedrine, 
and phenylpropanolamine in the Federal Register on October 5, 2016. 81 
FR 69079. This notice stated that the

[[Page 51294]]

Administrator would adjust, as needed, the established aggregate 
production quotas in 2017 in accordance with 21 CFR 1303.13 and 21 CFR 
1315.13. The 2017 proposed adjusted aggregate production quotas for 
controlled substances in schedules I and II and assessment of annual 
needs for the list I chemicals ephedrine, pseudoephedrine, and 
phenylpropanolamine were subsequently published in the Federal Register 
on August 4, 2017, (82 FR 36449) in consideration of the outlined 
criteria. All interested persons were invited to comment on or object 
to the proposed adjusted aggregate production quotas and assessment of 
annual needs on or before September 5, 2017.

Comments Received

    Three DEA-registered entities submitted timely comments regarding a 
total of eleven schedule I and II controlled substances. Comments 
received proposed that the aggregate production quotas for amphetamine 
(for conversion), dihydrocodeine, diphenoxylate (for sale), heroin, 
levorphanol, lisdexamfetmine, methadone intermediate, noroxymorphone 
(for conversion), oripavine, oxycodone (for sale), and oxymorphone (for 
conversion) were insufficient to provide for the estimated medical, 
scientific, research, and industrial needs of the United States, for 
export requirements, and for the establishment and maintenance of 
reserve stocks. The DEA received 43 comments from non-DEA registered 
entities in response to the DEA's August 4, 2017, press release for the 
proposed 2018 aggregate production quotas. The majority of these 
commenters expressed concerns about the 20 percent decrease to the 
production quotas of controlled substances. The DEA also received two 
comments from non-DEA registered entities suggesting that the 
rescheduling of marihuana would drastically reduce opioid use, misuse, 
and addiction. These 45 comments addressed issues that were outside the 
scope of this final order, and therefore are not relevant to the 
analysis involved in finalizing the 2017 aggregate production quotas.
    The DEA received no comments from DEA-registered or non-DEA 
registered entities for previously established values of the 2017 
assessment of annual needs for ephedrine, pseudoephedrine, and 
phenylpropanolamine.

Analysis for Final Adjusted 2017 Aggregate Production Quotas and 
Assessment of Annual Needs

    In determining the final adjusted 2017 aggregate production quotas 
and assessment of annual needs, the DEA has taken into consideration 
the above comments that are specifically relevant to this Final Order 
for calendar year 2017 along with the factors set forth in 21 CFR 
1303.13 and 21 CFR 1315.13 in accordance with 21 U.S.C. 826(a), and 
other relevant factors including the 2016 year-end inventories, initial 
2017 manufacturing and import quotas, 2017 export requirements, actual 
and projected 2017 sales, research and product development 
requirements, and additional applications received. Based on all of the 
above, the Administrator is adjusting the 2017 aggregate production 
quotas and assessment of annual needs for 4-Anilino-N-Phenethyl-4-
Piperidine (ANPP), dihydrocodeine, ephedrine (for sale), fentanyl, 
hydrocodone (for sale), meperidine, methadone intermediate, morphine 
(for sale), opium (tincture), Oripavine, oxycodone (for sale), 
Oxymorphone (for conversion), Oxymorphone (for sale), 
phenylpropanolamine (for conversion), phenylpropanolamine (for sale), 
pseudoephedrine (for sale), tapentadol, and thiafentanil. This final 
order reflects those adjustments.
    Regarding diphenoxylate (for sale), heroin, levorphanol, and 
noroxymorphone (for conversion) the Administrator hereby determines 
that the proposed adjusted 2017 aggregate production quotas and 
assessment of annual needs for these substances and list I chemicals as 
published on August 4, 2017, (82 FR 36449) are sufficient to meet the 
current 2017 estimated medical, scientific, research, and industrial 
needs of the United States and to provide for adequate reserve stock. 
This final order establishes these aggregate production quotas at the 
same amounts as proposed.
    Pursuant to the above, the Administrator hereby finalizes the 2017 
aggregate production quotas for the following schedule I and II 
controlled substances and the 2017 assessment of annual needs for the 
list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine, 
expressed in grams of anhydrous acid or base, as follows:

------------------------------------------------------------------------
                                                          Final revised
                      Basic class                        2017 quotas (g)
------------------------------------------------------------------------
                               Schedule I
------------------------------------------------------------------------
1-(1-Phenylcyclohexyl)pyrrolidine......................               10
1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201)......               30
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694).....               30
1-[1-(2-Thienyl)cyclohexyl]piperidine..................               15
1-Benzylpiperazine.....................................               25
1-Methyl-4-phenyl-4-propionoxypiperidine...............                2
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).......               30
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)......               30
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N)......               30
2-(2,5-Dimethoxy-4-n-propylphenyl)ethanamine (2C-P)....               30
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)...............               30
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-                                 25
 methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B;
 Cimbi-36).............................................
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)......               30
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-                                25
 methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C;
 Cimbi-82).............................................
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)........               30
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-                                  30
 methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I;
 Cimbi-5)..............................................
2,5-Dimethoxy-4-ethylamphetamine (DOET)................               25
2,5-Dimethoxy-4-n-propylthiophenethylamine.............               25
2,5-Dimethoxyamphetamine...............................               25
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-                30
 2)....................................................
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-              30
 T-4)..................................................
3,4,5-Trimethoxyamphetamine............................               25
3,4-Methylenedioxyamphetamine (MDA)....................               55

[[Page 51295]]

 
3,4-Methylenedioxymethamphetamine (MDMA)...............               50
3,4-Methylenedioxy-N-ethylamphetamine (MDEA)...........               40
3,4-Methylenedioxy-N-methylcathinone (methylone).......               40
3,4-Methylenedioxypyrovalerone (MDPV)..................               35
3-FMC; 3-Fluoro-N-methylcathinone......................               25
3-Methylfentanyl.......................................               30
3-Methylthiofentanyl...................................               30
4-Bromo-2,5-dimethoxyamphetamine (DOB).................               25
4-Bromo-2,5-dimethoxyphenethylamine (2-CB).............               25
4-Fluoroisobutyryl fentanyl............................               30
4-FMC; Flephedrone.....................................               25
4-MEC; 4-Methyl-N-ethylcathinone.......................               25
4-Methoxyamphetamine...................................              150
4-Methyl-2,5-dimethoxyamphetamine (DOM)................               25
4-Methylaminorex.......................................               25
4-Methyl-N-methylcathinone (mephedrone)................               45
4-Methyl-[alpha]-pyrrolidinopropiophenone (4-MePPP)....               25
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-               50
 phenol................................................
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-                40
 phenol (cannabicyclohexanol or CP-47,497 C8-homolog)..
5F-ADB; 5F-MDMB-PINACA (methyl 2-(1-(5-fluoropentyl)-1H-              30
 indazole-3-carboxamido)-3,3-dimethylbutanoate)........
5F-AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-                   30
 carboxamido)-3-methylbutanoate).......................
5F-APINACA; 5F-AKB48 (N-(adamantan-1-yl)-1-(5-                        30
 fluoropentyl)-1H-indazole-3-carboxamide)..............
5-Fluoro-PB-22; 5F-PB-22...............................               20
5-Fluoro-UR144, XLR11 ([1-(5-fluoro-pentyl)-1Hindol-3-                25
 yl](2,2,3,3-tetramethylcyclopropyl)methanone..........
5-Methoxy-3,4-methylenedioxyamphetamine................               25
5-Methoxy-N,N-diisopropyltryptamine....................               25
5-Methoxy-N,N-dimethyltryptamine.......................               25
AB-CHMINACA............................................               30
AB-FUBINACA............................................               50
AB-PINACA..............................................               30
Acetyl Fentanyl........................................              100
Acetyl-alpha-methylfentanyl............................               30
Acetyldihydrocodeine...................................               30
Acetylmethadol.........................................                2
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-               30
 1-(4-fluorobenzyl)-1H-indazole-3-carboxamide).........
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-               50
 pentyl-1H-indazole-3-carboxamide).....................
AH-7921................................................               30
Allylprodine...........................................                2
Alphacetylmethadol.....................................                2
alpha-Ethyltryptamine..................................               25
Alphameprodine.........................................                2
Alphamethadol..........................................                2
alpha-Methylfentanyl...................................               30
alpha-Methylthiofentanyl...............................               30
alpha-Methyltryptamine (AMT)...........................               25
alpha-Pyrrolidinobutiophenone ([alpha]-PBP)............               25
alpha-Pyrrolidinopentiophenone ([alpha]-PVP)...........               25
Aminorex...............................................               25
APINCA, AKB48 (N-(1-adamantyl)-1-pentyl-1H-indazole-3-                25
 carboxamide)..........................................
Benzylmorphine.........................................               30
Betacetylmethadol......................................                2
beta-Hydroxy-3-methylfentanyl..........................               30
beta-Hydroxyfentanyl...................................               30
beta-Hydroxythiofentanyl...............................               30
Betameprodine..........................................                2
Betamethadol...........................................                4
Betaprodine............................................                2
Bufotenine.............................................                3
Butylone...............................................               25
Butyryl Fentanyl.......................................               30
Cathinone..............................................               24
Codeine Methylbromide..................................               30
Codeine-N-oxide........................................              330
Desomorphine...........................................               25
Diethyltryptamine......................................               25
Difenoxin..............................................            8,750
Dihydromorphine........................................        1,566,000
Dimethyltryptamine.....................................               35
Dipipanone.............................................                5
Etorphine..............................................               30
Fenethylline...........................................               30
Furanyl Fentanyl.......................................               30

[[Page 51296]]

 
gamma-Hydroxybutyric acid..............................       56,200,000
Heroin.................................................               45
Hydromorphinol.........................................                2
Hydroxypethidine.......................................                2
Ibogaine...............................................               30
JWH-018 and AM678 (1-Pentyl-3-(1-naphthoyl)indole).....               35
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)................               45
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)................               45
JWH-081 (1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole)....               30
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole)......               30
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-                             35
 naphthoyl)indole).....................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole)......               30
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).....               30
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole)......               30
Lysergic acid diethylamide (LSD).......................               40
MAB-CHMINACA; ADB-CHMINACA (N-(1-amino-3,3-dimethyl-1-                30
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
 carboxamide)..........................................
MDMB-CHMICA; MMB-CHMINACA(methyl 2-(1-                                30
 (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-
 dimethylbutanoate)....................................
MDMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole-              30
 3-carboxamido)-3,3-dimethylbutanoate).................
Marihuana..............................................          472,000
Mecloqualone...........................................               30
Mescaline..............................................               25
Methaqualone...........................................               60
Methcathinone..........................................               25
Methyldesorphine.......................................                5
Methyldihydromorphine..................................                2
Morphine methylbromide.................................                5
Morphine methylsulfonate...............................                5
Morphine-N-oxide.......................................              350
N,N-Dimethylamphetamine................................               25
Naphyrone..............................................               25
N-Ethyl-1-phenylcyclohexylamine........................                5
N-Ethylamphetamine.....................................               24
N-Hydroxy-3,4-methylenedioxyamphetamine................               24
Noracymethadol.........................................                2
Norlevorphanol.........................................               55
Normethadone...........................................                2
Normorphine............................................               40
para-Fluorofentanyl....................................               25
Parahexyl..............................................                5
PB-22; QUPIC...........................................               20
Pentedrone.............................................               25
Pentylone..............................................               25
Phenomorphan...........................................                2
Pholcodine.............................................                5
Psilocybin.............................................               30
Psilocyn...............................................               50
SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2-                              45
 methoxyphenylacetyl)indole)...........................
SR-19 and RCS-4 (1-Pentyl-3-[(4-methoxy)-                             30
 benzoyl]indole).......................................
Tetrahydrocannabinols..................................          409,000
Thiofentanil...........................................               25
THJ-2201 ( [1-(5-fluoropentyl)-1H-indazol-3-                          30
 yl](naphthalen-1-yl)methanone)........................
Tilidine...............................................               25
Trimeperidine..........................................                2
U-47700................................................               30
UR-144 (1-pentyl-1H-indol-3-yl)(2,2,3,3-                              25
 tetramethylcyclopropyl)methanone......................
------------------------------------------------------------------------
                               Schedule II
------------------------------------------------------------------------
1-Phenylcyclohexylamine................................                4
1-Piperidinocyclohexanecarbonitrile....................                4
4-Anilino-N-phenethyl-4-piperidine (ANPP)..............        1,050,000
Alfentanil.............................................            4,200
Alphaprodine...........................................                2
Amobarbital............................................           20,100
Amphetamine (for conversion)...........................       12,000,000
Amphetamine (for sale).................................       42,400,000
Carfentanil............................................               20
Cocaine................................................          103,400
Codeine (for conversion)...............................       40,000,000
Codeine (for sale).....................................       45,000,000
Dextropropoxyphene.....................................               35

[[Page 51297]]

 
Dihydrocodeine.........................................          360,000
Dihydroetorphine.......................................                2
Diphenoxylate (for conversion).........................           15,000
Diphenoxylate (for sale)...............................        1,110,000
Ecgonine...............................................           99,000
Ethylmorphine..........................................               30
Etorphine Hydrochloride................................               32
Fentanyl...............................................        1,350,000
Glutethimide...........................................                2
Hydrocodone (for conversion)...........................          122,000
Hydrocodone (for sale).................................       51,900,000
Hydromorphone..........................................        5,140,800
Isomethadone...........................................               30
Levo-alphacetylmethadol (LAAM).........................                5
Levomethorphan.........................................               30
Levorphanol............................................           12,900
Lisdexamfetamine.......................................       19,000,000
Meperidine.............................................        2,904,000
Meperidine Intermediate-A..............................                5
Meperidine Intermediate-B..............................               30
Meperidine Intermediate-C..............................                5
Metazocine.............................................               15
Methadone (for sale)...................................       23,700,000
Methadone Intermediate.................................       28,700,000
Methamphetamine........................................        1,539,100
------------------------------------------------------------------------
[900,000 grams of levo-desoxyephedrine for use in a non-controlled, non-
 prescription product; 600,000 grams for methamphetamine mostly for
 conversion to a schedule III product; and 39,100 grams for
 methamphetamine (for sale)]............................................
------------------------------------------------------------------------
Methylphenidate........................................       73,000,000
Morphine (for conversion)..............................       27,300,000
Morphine (for sale)....................................       35,000,000
Nabilone...............................................           19,000
Noroxymorphone (for conversion)........................       17,700,000
Noroxymorphone (for sale)..............................          400,000
Opium (powder).........................................           90,000
Opium (tincture).......................................          500,000
Oripavine..............................................       28,900,000
Oxycodone (for conversion).............................        2,610,000
Oxycodone (for sale)...................................      101,500,000
Oxymorphone (for conversion)...........................       23,000,000
Oxymorphone (for sale).................................        3,600,000
Pentobarbital..........................................       27,500,000
Phenazocine............................................                5
Phencyclidine..........................................               35
Phenmetrazine..........................................               25
Phenylacetone..........................................               40
Racemethorphan.........................................                5
Racemorphan............................................                5
Remifentanil...........................................            3,000
Secobarbital...........................................          172,002
Sufentanil.............................................            4,000
Tapentadol.............................................       18,600,000
Thiafentanil...........................................               30
Thebaine...............................................      100,000,000
------------------------------------------------------------------------
                            List I Chemicals
------------------------------------------------------------------------
Ephedrine (for conversion).............................           50,000
Ephedrine (for sale)...................................        4,810,000
Phenylpropanolamine (for conversion)...................       13,600,000
Phenylpropanolamine (for sale).........................        7,000,000
Pseudoephedrine (for conversion).......................               40
Pseudoephedrine (for sale).............................      186,000,000
------------------------------------------------------------------------


[[Page 51298]]

    Aggregate production quotas for all other schedule I and II 
controlled substances included in 21 CFR 1308.11 and 1308.12 remain at 
zero.

    Dated: October 27, 2017.
Robert W. Patterson,
Acting Administrator.
[FR Doc. 2017-24009 Filed 11-2-17; 8:45 am]
BILLING CODE 4410-09-P
Federal Register / Vol. 82, No. 212 / Friday, November 3, 2017 / Notices 51293

(‘‘the ’557 patent’’). The complaint required by subsection (a)(2) of section Issued: October 31, 2017.
further alleges that an industry in the 337; Lisa R. Barton,
United States exists as required by the (2) For the purpose of the Secretary to the Commission.
applicable Federal Statute. investigation so instituted, the following [FR Doc. 2017–24004 Filed 11–2–17; 8:45 am]
The complainant requests that the are hereby named as parties upon which BILLING CODE 7020–02–P
Commission institute an investigation this notice of investigation shall be
and, after the investigation, issue a served:
limited exclusion order and cease and DEPARTMENT OF JUSTICE
(a) The complainant is: Tessera
desist orders.
Advanced Technologies, Inc., 3025
ADDRESSES: The complaint, except for Orchard Parkway, San Jose, CA 95134. Drug Enforcement Administration
any confidential information contained [Docket No. DEA–470F]
(b) The respondents are the following
therein, is available for inspection
entities alleged to be in violation of
during official business hours (8:45 a.m. Final Adjusted Aggregate Production
section 337, and are the parties upon
to 5:15 p.m.) in the Office of the Quotas for Schedule I and II Controlled
which the complaint is to be served:
Secretary, U.S. International Trade Substances and Assessment of
Commission, 500 E Street SW., Room Samsung Electronics Co., Ltd., 129 Annual Needs for the List I Chemicals
112, Washington, DC 20436, telephone Samsung-ro, Maetan-3dong, Yeongtong- Ephedrine, Pseudoephedrine, and
(202) 205–2000. Hearing impaired gu, Suwon-si, Gyeonggi-do, Republic of Phenylpropanolamine for 2017
individuals are advised that information Korea 443–742.
on this matter can be obtained by AGENCY: Drug Enforcement
Samsung Electronics America, Inc., 85
contacting the Commission’s TDD Administration (DEA), Department of
Challenger Road, Ridgefield Park, NJ
terminal on (202) 205–1810. Persons Justice (DOJ).
07660.
with mobility impairments who will ACTION: Final order.
Samsung Semiconductor, Inc., 3655
need special assistance in gaining access N. 1st Street, San Jose, CA 95134. SUMMARY: This final order establishes
to the Commission should contact the the final adjusted 2017 aggregate
Office of the Secretary at (202) 205– (3) For the investigation so instituted,
the Chief Administrative Law Judge, production quotas for controlled
2000. General information concerning substances in schedules I and II of the
the Commission may also be obtained U.S. International Trade Commission,
shall designate the presiding Controlled Substances Act and the
by accessing its internet server at assessment of annual needs for the list
https://www.usitc.gov. The public Administrative Law Judge.
I chemicals ephedrine,
record for this investigation may be The Office of Unfair Import
pseudoephedrine, and
viewed on the Commission’s electronic Investigations will not participate as a
phenylpropanolamine.
docket (EDIS) at https://edis.usitc.gov. party in this investigation.
Responses to the complaint and the This order is applicable
DATES:
FOR FURTHER INFORMATION CONTACT:
notice of investigation must be November 3, 2017.
Katherine Hiner, The Office of
Secretary, Docket Services, U.S. submitted by the named respondents in FOR FURTHER INFORMATION CONTACT:
International Trade Commission, accordance with section 210.13 of the Michael J. Lewis, Diversion Control
telephone (202) 205–1802. Commission’s Rules of Practice and Division, Drug Enforcement
Procedure, 19 CFR 210.13. Pursuant to Administration, 8701 Morrissette Drive,
SUPPLEMENTARY INFORMATION: Springfield, VA 22152, Telephone: (202)
Authority: The authority for 19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the 598–6812.
institution of this investigation is SUPPLEMENTARY INFORMATION:
contained in section 337 of the Tariff Commission if received not later than 20
Act of 1930, as amended, 19 U.S.C. 1337 days after the date of service by the Legal Authority
and in section 210.10 of the Commission of the complaint and the
notice of investigation. Extensions of Section 306 of the Controlled
Commission’s Rules of Practice and Substances Act (CSA) (21 U.S.C. 826)
Procedure, 19 CFR 210.10 (2017). time for submitting responses to the
complaint and the notice of requires the Attorney General to
Scope of Investigation: Having establish aggregate production quotas
investigation will not be granted unless
considered the complaint, the U.S. for each basic class of controlled
good cause therefor is shown.
International Trade Commission, on substances listed in schedules I and II
October 30, 2017, Ordered that— Failure of a respondent to file a timely and for the list I chemicals ephedrine,
(1) Pursuant to subsection (b) of response to each allegation in the pseudoephedrine, and
section 337 of the Tariff Act of 1930, as complaint and in this notice may be phenylpropanolamine. The Attorney
amended, an investigation be instituted deemed to constitute a waiver of the General has delegated this function to
to determine whether there is a right to appear and contest the the Administrator of the Drug
violation of subsection (a)(1)(B) of allegations of the complaint and this Enforcement Administration (DEA)
section 337 in the importation into the notice, and to authorize the pursuant to 28 CFR 0.100.
United States, the sale for importation, administrative law judge and the
or the sale within the United States after Commission, without further notice to Background
importation of certain wafer-level the respondent, to find the facts to be as The DEA published the 2017
packaging semiconductor devices and alleged in the complaint and this notice established aggregate production quotas
ethrower on DSK3G9T082PROD with NOTICES

products containing same (including and to enter an initial determination for controlled substances in schedules I
cellular phones, tablets, laptops, and and a final determination containing and II and for the assessment of annual
notebooks) and components thereof by such findings, and may result in the needs for the list I chemicals ephedrine,
reason of infringement of one or more of issuance of an exclusion order or a cease pseudoephedrine, and
claims 1–8 of the ’557 patent and claims and desist order or both directed against phenylpropanolamine in the Federal
1–18 of the ’001 patent; and whether an the respondent. Register on October 5, 2016. 81 FR
industry in the United States exists as By order of the Commission. 69079. This notice stated that the

VerDate Sep<11>2014 16:18 Nov 02, 2017 Jkt 244001 PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 E:\FR\FM\03NON1.SGM 03NON1
Federal Register / Vol. 82, No. 212 / Friday, November 3, 2017 / Notices 51295

Final revised
Basic class 2017 quotas
(g)

3,4-Methylenedioxymethamphetamine (MDMA) ............................................................................................................................... 50
3,4-Methylenedioxy-N-ethylamphetamine (MDEA) ........................................................................................................................... 40
3,4-Methylenedioxy-N-methylcathinone (methylone) ........................................................................................................................ 40
3,4-Methylenedioxypyrovalerone (MDPV) ......................................................................................................................................... 35
3-FMC; 3-Fluoro-N-methylcathinone ................................................................................................................................................. 25
3-Methylfentanyl ................................................................................................................................................................................. 30
3-Methylthiofentanyl ........................................................................................................................................................................... 30
4-Bromo-2,5-dimethoxyamphetamine (DOB) .................................................................................................................................... 25
4-Bromo-2,5-dimethoxyphenethylamine (2–CB) ............................................................................................................................... 25
4-Fluoroisobutyryl fentanyl ................................................................................................................................................................. 30
4-FMC; Flephedrone .......................................................................................................................................................................... 25
4-MEC; 4-Methyl-N-ethylcathinone .................................................................................................................................................... 25
4-Methoxyamphetamine .................................................................................................................................................................... 150
4-Methyl-2,5-dimethoxyamphetamine (DOM) .................................................................................................................................... 25
4-Methylaminorex .............................................................................................................................................................................. 25
4-Methyl-N-methylcathinone (mephedrone) ...................................................................................................................................... 45
4-Methyl-a-pyrrolidinopropiophenone (4-MePPP) ............................................................................................................................. 25
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol ....................................................................................................... 50
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) ......................... 40
5F-ADB; 5F-MDMB-PINACA (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .......................... 30
5F-AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ................................................................. 30
5F-APINACA; 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ...................................................... 30
5-Fluoro-PB-22; 5F-PB-22 ................................................................................................................................................................. 20
5-Fluoro-UR144, XLR11 ([1-(5-fluoro-pentyl)-1Hindol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .......................................... 25
5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................................... 25
5-Methoxy-N,N-diisopropyltryptamine ................................................................................................................................................ 25
5-Methoxy-N,N-dimethyltryptamine ................................................................................................................................................... 25
AB-CHMINACA .................................................................................................................................................................................. 30
AB-FUBINACA ................................................................................................................................................................................... 50
AB-PINACA ........................................................................................................................................................................................ 30
Acetyl Fentanyl .................................................................................................................................................................................. 100
Acetyl-alpha-methylfentanyl ............................................................................................................................................................... 30
Acetyldihydrocodeine ......................................................................................................................................................................... 30
Acetylmethadol .................................................................................................................................................................................. 2
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ................................ 30
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................................... 50
AH-7921 ............................................................................................................................................................................................. 30
Allylprodine ........................................................................................................................................................................................ 2
Alphacetylmethadol ............................................................................................................................................................................ 2
alpha-Ethyltryptamine ........................................................................................................................................................................ 25
Alphameprodine ................................................................................................................................................................................. 2
Alphamethadol ................................................................................................................................................................................... 2
alpha-Methylfentanyl .......................................................................................................................................................................... 30
alpha-Methylthiofentanyl .................................................................................................................................................................... 30
alpha-Methyltryptamine (AMT) .......................................................................................................................................................... 25
alpha-Pyrrolidinobutiophenone (a-PBP) ............................................................................................................................................ 25
alpha-Pyrrolidinopentiophenone (a-PVP) .......................................................................................................................................... 25
Aminorex ............................................................................................................................................................................................ 25
APINCA, AKB48 (N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ....................................................................................... 25
Benzylmorphine ................................................................................................................................................................................. 30
Betacetylmethadol ............................................................................................................................................................................. 2
beta-Hydroxy-3-methylfentanyl .......................................................................................................................................................... 30
beta-Hydroxyfentanyl ......................................................................................................................................................................... 30
beta-Hydroxythiofentanyl ................................................................................................................................................................... 30
Betameprodine ................................................................................................................................................................................... 2
Betamethadol ..................................................................................................................................................................................... 4
Betaprodine ........................................................................................................................................................................................ 2
Bufotenine .......................................................................................................................................................................................... 3
Butylone ............................................................................................................................................................................................. 25
Butyryl Fentanyl ................................................................................................................................................................................. 30
Cathinone ........................................................................................................................................................................................... 24
Codeine Methylbromide ..................................................................................................................................................................... 30
Codeine-N-oxide ................................................................................................................................................................................ 330
Desomorphine .................................................................................................................................................................................... 25
ethrower on DSK3G9T082PROD with NOTICES

Diethyltryptamine ............................................................................................................................................................................... 25
Difenoxin ............................................................................................................................................................................................ 8,750
Dihydromorphine ................................................................................................................................................................................ 1,566,000
Dimethyltryptamine ............................................................................................................................................................................ 35
Dipipanone ......................................................................................................................................................................................... 5
Etorphine ............................................................................................................................................................................................ 30
Fenethylline ........................................................................................................................................................................................ 30
Furanyl Fentanyl ................................................................................................................................................................................ 30

VerDate Sep<11>2014 16:18 Nov 02, 2017 Jkt 244001 PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 E:\FR\FM\03NON1.SGM 03NON1
51296 Federal Register / Vol. 82, No. 212 / Friday, November 3, 2017 / Notices

Final revised
Basic class 2017 quotas
(g)

gamma-Hydroxybutyric acid .............................................................................................................................................................. 56,200,000
Heroin ................................................................................................................................................................................................ 45
Hydromorphinol .................................................................................................................................................................................. 2
Hydroxypethidine ............................................................................................................................................................................... 2
Ibogaine ............................................................................................................................................................................................. 30
JWH-018 and AM678 (1-Pentyl-3-(1-naphthoyl)indole) .................................................................................................................... 35
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ......................................................................................................................................... 45
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) .......................................................................................................................................... 45
JWH-081 (1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole) ..................................................................................................................... 30
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) ......................................................................................................................... 30
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ............................................................................................................. 35
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) .......................................................................................................................... 30
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) ...................................................................................................................... 30
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) .......................................................................................................................... 30
Lysergic acid diethylamide (LSD) ...................................................................................................................................................... 40
MAB-CHMINACA; ADB-CHMINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide) .................................................................................................................................................................................. 30
MDMB-CHMICA; MMB-CHMINACA(methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ............... 30
MDMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......................................... 30
Marihuana .......................................................................................................................................................................................... 472,000
Mecloqualone ..................................................................................................................................................................................... 30
Mescaline ........................................................................................................................................................................................... 25
Methaqualone .................................................................................................................................................................................... 60
Methcathinone ................................................................................................................................................................................... 25
Methyldesorphine ............................................................................................................................................................................... 5
Methyldihydromorphine ...................................................................................................................................................................... 2
Morphine methylbromide ................................................................................................................................................................... 5
Morphine methylsulfonate .................................................................................................................................................................. 5
Morphine-N-oxide .............................................................................................................................................................................. 350
N,N-Dimethylamphetamine ................................................................................................................................................................ 25
Naphyrone ......................................................................................................................................................................................... 25
N-Ethyl-1-phenylcyclohexylamine ...................................................................................................................................................... 5
N-Ethylamphetamine ......................................................................................................................................................................... 24
N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................................... 24
Noracymethadol ................................................................................................................................................................................. 2
Norlevorphanol ................................................................................................................................................................................... 55
Normethadone ................................................................................................................................................................................... 2
Normorphine ...................................................................................................................................................................................... 40
para-Fluorofentanyl ............................................................................................................................................................................ 25
Parahexyl ........................................................................................................................................................................................... 5
PB-22; QUPIC ................................................................................................................................................................................... 20
Pentedrone ........................................................................................................................................................................................ 25
Pentylone ........................................................................................................................................................................................... 25
Phenomorphan .................................................................................................................................................................................. 2
Pholcodine ......................................................................................................................................................................................... 5
Psilocybin ........................................................................................................................................................................................... 30
Psilocyn .............................................................................................................................................................................................. 50
SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) ......................................................................................... 45
SR-19 and RCS-4 (1-Pentyl-3-[(4-methoxy)-benzoyl]indole) ............................................................................................................ 30
Tetrahydrocannabinols ...................................................................................................................................................................... 409,000
Thiofentanil ........................................................................................................................................................................................ 25
THJ-2201 ( [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .................................................................................. 30
Tilidine ................................................................................................................................................................................................ 25
Trimeperidine ..................................................................................................................................................................................... 2
U-47700 ............................................................................................................................................................................................. 30
UR-144 (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................................... 25

Schedule II

1-Phenylcyclohexylamine .................................................................................................................................................................. 4
1-Piperidinocyclohexanecarbonitrile .................................................................................................................................................. 4
4-Anilino-N-phenethyl-4-piperidine (ANPP) ....................................................................................................................................... 1,050,000
Alfentanil ............................................................................................................................................................................................ 4,200
Alphaprodine ...................................................................................................................................................................................... 2
ethrower on DSK3G9T082PROD with NOTICES

Amobarbital ........................................................................................................................................................................................ 20,100
Amphetamine (for conversion) .......................................................................................................................................................... 12,000,000
Amphetamine (for sale) ..................................................................................................................................................................... 42,400,000
Carfentanil .......................................................................................................................................................................................... 20
Cocaine .............................................................................................................................................................................................. 103,400
Codeine (for conversion) ................................................................................................................................................................... 40,000,000
Codeine (for sale) .............................................................................................................................................................................. 45,000,000
Dextropropoxyphene .......................................................................................................................................................................... 35

VerDate Sep<11>2014 16:18 Nov 02, 2017 Jkt 244001 PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 E:\FR\FM\03NON1.SGM 03NON1
Federal Register / Vol. 82, No. 212 / Friday, November 3, 2017 / Notices 51297

Final revised
Basic class 2017 quotas
(g)

Dihydrocodeine .................................................................................................................................................................................. 360,000
Dihydroetorphine ................................................................................................................................................................................ 2
Diphenoxylate (for conversion) .......................................................................................................................................................... 15,000
Diphenoxylate (for sale) ..................................................................................................................................................................... 1,110,000
Ecgonine ............................................................................................................................................................................................ 99,000
Ethylmorphine .................................................................................................................................................................................... 30
Etorphine Hydrochloride .................................................................................................................................................................... 32
Fentanyl ............................................................................................................................................................................................. 1,350,000
Glutethimide ....................................................................................................................................................................................... 2
Hydrocodone (for conversion) ........................................................................................................................................................... 122,000
Hydrocodone (for sale) ...................................................................................................................................................................... 51,900,000
Hydromorphone ................................................................................................................................................................................. 5,140,800
Isomethadone .................................................................................................................................................................................... 30
Levo-alphacetylmethadol (LAAM) ...................................................................................................................................................... 5
Levomethorphan ................................................................................................................................................................................ 30
Levorphanol ....................................................................................................................................................................................... 12,900
Lisdexamfetamine .............................................................................................................................................................................. 19,000,000
Meperidine ......................................................................................................................................................................................... 2,904,000
Meperidine Intermediate-A ................................................................................................................................................................ 5
Meperidine Intermediate-B ................................................................................................................................................................ 30
Meperidine Intermediate-C ................................................................................................................................................................ 5
Metazocine ......................................................................................................................................................................................... 15
Methadone (for sale) ......................................................................................................................................................................... 23,700,000
Methadone Intermediate .................................................................................................................................................................... 28,700,000
Methamphetamine ............................................................................................................................................................................. 1,539,100

[900,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 600,000 grams for methamphetamine mostly for
conversion to a schedule III product; and 39,100 grams for methamphetamine (for sale)]

Methylphenidate ................................................................................................................................................................................. 73,000,000
Morphine (for conversion) .................................................................................................................................................................. 27,300,000
Morphine (for sale) ............................................................................................................................................................................ 35,000,000
Nabilone ............................................................................................................................................................................................. 19,000
Noroxymorphone (for conversion) ..................................................................................................................................................... 17,700,000
Noroxymorphone (for sale) ................................................................................................................................................................ 400,000
Opium (powder) ................................................................................................................................................................................. 90,000
Opium (tincture) ................................................................................................................................................................................. 500,000
Oripavine ............................................................................................................................................................................................ 28,900,000
Oxycodone (for conversion) .............................................................................................................................................................. 2,610,000
Oxycodone (for sale) ......................................................................................................................................................................... 101,500,000
Oxymorphone (for conversion) .......................................................................................................................................................... 23,000,000
Oxymorphone (for sale) ..................................................................................................................................................................... 3,600,000
Pentobarbital ...................................................................................................................................................................................... 27,500,000
Phenazocine ...................................................................................................................................................................................... 5
Phencyclidine ..................................................................................................................................................................................... 35
Phenmetrazine ................................................................................................................................................................................... 25
Phenylacetone ................................................................................................................................................................................... 40
Racemethorphan ............................................................................................................................................................................... 5
Racemorphan .................................................................................................................................................................................... 5
Remifentanil ....................................................................................................................................................................................... 3,000
Secobarbital ....................................................................................................................................................................................... 172,002
Sufentanil ........................................................................................................................................................................................... 4,000
Tapentadol ......................................................................................................................................................................................... 18,600,000
Thiafentanil ........................................................................................................................................................................................ 30
Thebaine ............................................................................................................................................................................................ 100,000,000

List I Chemicals

Ephedrine (for conversion) ................................................................................................................................................................ 50,000
Ephedrine (for sale) ........................................................................................................................................................................... 4,810,000
Phenylpropanolamine (for conversion) .............................................................................................................................................. 13,600,000
Phenylpropanolamine (for sale) ......................................................................................................................................................... 7,000,000
Pseudoephedrine (for conversion) .................................................................................................................................................... 40
Pseudoephedrine (for sale) ............................................................................................................................................................... 186,000,000
ethrower on DSK3G9T082PROD with NOTICES

VerDate Sep<11>2014 16:18 Nov 02, 2017 Jkt 244001 PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 E:\FR\FM\03NON1.SGM 03NON1
51298 Federal Register / Vol. 82, No. 212 / Friday, November 3, 2017 / Notices

Aggregate production quotas for all Administrator of the DEA Diversion control laws at United Rolls’ iron
other schedule I and II controlled Control Division (‘‘Assistant foundry facility in Canton, Ohio. The
substances included in 21 CFR 1308.11 Administrator’’) pursuant to section 7 of Complaint alleges violations of
and 1308.12 remain at zero. 28 CFR part 0, appendix to subpart R. recordkeeping and reporting
Dated: October 27, 2017. In accordance with 21 CFR requirements, as well as failure to meet
Robert W. Patterson, 1301.34(a), this is notice that on March requirements for the control of
17, 2017, Rhodes Technologies, 498 particulate matter emissions from
Acting Administrator.
Washington Street, Coventry, Rhode United Rolls’ facility. The proposed
[FR Doc. 2017–24009 Filed 11–2–17; 8:45 am]
Island 02816 applied to be registered as Consent Decree would require United
BILLING CODE 4410–09–P
an importer the following basic classes Rolls to perform emissions testing,
of controlled substances: upgrade an air pollution control
DEPARTMENT OF JUSTICE Controlled monitoring system, and take other steps
Drug code Schedule to control air pollutant emissions from
substance
Drug Enforcement Administration its Canton facility. United Rolls also
[Docket No. DEA–392] Tetrahydrocann- 7370 I would pay a total of $310,000 in civil
abinols. penalties (with $186,000 payable to the
Importer of Controlled Substances Methylphenidate 1724 II
Oxycodone ....... 9143 II
United States and $124,000 payable to
Application: Rhodes Technologies the State).
Hydromorphone 9150 II
ACTION: Notice of application. Hydrocodone .... 9193 II The publication of this notice opens
Morphine ........... 9300 II a period for public comment on the
DATES: Registered bulk manufacturers of Oxymorphone ... 9652 II
proposed Consent Decree. Comments
the affected basic classes, and Opium, raw ....... 9600 II
Poppy Straw 9670 II should be addressed to the Acting
applicants therefore, may file written Concentrate. Assistant Attorney General,
comments on or objections to the Environment and Natural Resources
issuance of the proposed registration on The company plans to import opium, Division, and should refer to United
or before December 4, 2017. Such raw (9600) and poppy straw concentrate States and the State of Ohio v. United
persons may also file a written request (9670) in order to bulk manufacture Rolls Inc., D.J. Ref. No. 90–5–2–1–
for a hearing on the application on or controlled substances in Active 10704. All comments must be submitted
before December 4, 2017. Pharmaceutical Ingredient (API) form. no later than thirty (30) days after the
ADDRESSES: Written comments should The company distributes the publication date of this notice.
be sent to: Drug Enforcement manufactured APIs in bulk to its Comments may be submitted either by
Administration, Attention: DEA Federal customers. The company plans to email or by mail:
Register Representative/DRW, 8701 import the other listed controlled
Morrissette Drive, Springfield, Virginia substances for internal reference To submit
22152. All requests for hearing must be Send them to:
standards use only. The comparisons of comments:
sent to: Drug Enforcement foreign reference standards to the
Administration, Attn: Administrator, company’s domestically manufacture By email ....... pubcomment-ees.enrd@
8701 Morrissette Drive, Springfield, API will allow the company to export usdoj.gov.
Virginia 22152. All requests for hearing domestically manufacture API to foreign By mail ......... Assistant Attorney General,
should also be sent to: (1) Drug U.S. DOJ—ENRD, P.O.
markets.
Enforcement Administration, Attn: Box 7611, Washington, DC
Dated: October 31, 2017. 20044–7611.
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and Demetra Ashley,
(2) Drug Enforcement Administration, Acting Assistant Administrator. During the public comment period,
Attn: DEA Federal Register the proposed Consent Decree may be
[FR Doc. 2017–24012 Filed 11–2–17; 8:45 am]
Representative/DRW, 8701 Morrissette BILLING CODE 4410–09–P examined and downloaded at this
Drive, Springfield, Virginia 22152. Justice Department Web site: https://
Comments and requests for hearings on www.justice.gov/enrd/consent-decrees.
applications to import narcotic raw DEPARTMENT OF JUSTICE We will provide a paper copy of the
material are not appropriate. 72 FR 3417 Consent Decree upon written request
(January 25, 2007). Notice of Lodging of Proposed
Consent Decree Under the Clean Air and payment of reproduction costs.
SUPPLEMENTARY INFORMATION: The Please mail your request and payment
Act
Attorney General has delegated his to: Consent Decree Library, U.S. DOJ—
authority under the Controlled On October 27, 2017, the Department ENRD, P.O. Box 7611, Washington, DC
Substances Act to the Administrator of of Justice lodged a proposed Consent 20044–7611.
the Drug Enforcement Administration Decree with the United States District
Please enclose a check or money order
(DEA), 28 CFR 0.100(b). Authority to Court for the Northern District of Ohio
exercise all necessary functions with in the lawsuit entitled United States and for $16.25 (25 cents per page
respect to the promulgation and the State of Ohio v. United Rolls Inc., reproduction cost) payable to the United
implementation of 21 CFR part 1301, Civil Action No. 5:17–cv–02278. States Treasury.
ethrower on DSK3G9T082PROD with NOTICES

incident to the registration of The United States and the State of Randall M. Stone,
manufacturers, distributors, dispensers, Ohio filed a Complaint seeking civil Acting Assistant Section Chief,
importers, and exporters of controlled penalties and injunctive relief from Environmental Enforcement Section,
substances (other than final orders in Defendant United Rolls Inc. for alleged Environment and Natural Resources Division.
connection with suspension, denial, or violations of the Clean Air Act, 42 [FR Doc. 2017–23915 Filed 11–2–17; 8:45 am]
revocation of registration) has been U.S.C. 7401–7671q, and corresponding
BILLING CODE 4410–15–P
redelegated to the Assistant provisions of Ohio’s air pollution

VerDate Sep<11>2014 16:18 Nov 02, 2017 Jkt 244001 PO 00000 Frm 00089 Fmt 4703 Sfmt 9990 E:\FR\FM\03NON1.SGM 03NON1
Document Created: 2018-10-25 10:23:03
Document Modified: 2018-10-25 10:23:03
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Final order.
Dates		This order is applicable November 3, 2017.
Contact		Michael J. Lewis, Diversion Control Division, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone: (202) 598-6812.
FR Citation		82 FR 51293
82 FR 51293 - Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2017

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 82, Issue 212 (November 3, 2017)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration
